1. Home
  2. HOV vs IOVA Comparison

HOV vs IOVA Comparison

Compare HOV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOV
  • IOVA
  • Stock Information
  • Founded
  • HOV 1959
  • IOVA 2007
  • Country
  • HOV United States
  • IOVA United States
  • Employees
  • HOV N/A
  • IOVA N/A
  • Industry
  • HOV Homebuilding
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HOV Consumer Discretionary
  • IOVA Health Care
  • Exchange
  • HOV Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • HOV 843.6M
  • IOVA 771.4M
  • IPO Year
  • HOV N/A
  • IOVA N/A
  • Fundamental
  • Price
  • HOV $95.60
  • IOVA $1.98
  • Analyst Decision
  • HOV Sell
  • IOVA Buy
  • Analyst Count
  • HOV 2
  • IOVA 10
  • Target Price
  • HOV $120.00
  • IOVA $12.22
  • AVG Volume (30 Days)
  • HOV 137.7K
  • IOVA 11.2M
  • Earning Date
  • HOV 05-20-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • HOV N/A
  • IOVA N/A
  • EPS Growth
  • HOV N/A
  • IOVA N/A
  • EPS
  • HOV 28.18
  • IOVA N/A
  • Revenue
  • HOV $3,062,436,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • HOV $0.00
  • IOVA $86.62
  • Revenue Next Year
  • HOV $2.50
  • IOVA $69.95
  • P/E Ratio
  • HOV $3.25
  • IOVA N/A
  • Revenue Growth
  • HOV 7.85
  • IOVA 11070.12
  • 52 Week Low
  • HOV $81.15
  • IOVA $1.64
  • 52 Week High
  • HOV $240.34
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • HOV 49.04
  • IOVA 43.44
  • Support Level
  • HOV $90.84
  • IOVA $1.95
  • Resistance Level
  • HOV $99.53
  • IOVA $2.47
  • Average True Range (ATR)
  • HOV 5.77
  • IOVA 0.15
  • MACD
  • HOV 0.02
  • IOVA 0.05
  • Stochastic Oscillator
  • HOV 46.18
  • IOVA 35.53

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: